Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Brain Behav Immun. 2008 Nov;22(8):1197-200. doi: 10.1016/j.bbi.2008.05.009. Epub 2008 Jul 9.

Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings.

Author information

  • 1Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience and Human Behavior, USA.

Abstract

Converging evidence from basic and clinical studies suggests a role for proinflammatory cytokines in cancer-related fatigue, although the etiology of elevated inflammatory processes is unclear. We examined single nucleotide polymorphisms (SNPs) in the promoters of cytokine genes as genetic risk factors for cytokine-related fatigue in 33 fatigued and 14 non-fatigued breast cancer survivors, focusing on promoter sequence polymorphisms in IL1B and IL6 associated with differential expression of proinflammatory cytokines. Predictors of fatigue included presence of at least one cytosine at IL1B -511 (95%CI=0.91-16.6, p=.007) and homozygosity for either variant of the IL6 -174 genotype (G/G or C/C; 95%CI=1.12-17.9, p=.027). Associations between fatigue status and IL1B genotype remained significant after covariate adjustment for demographic, biobehavioral and treatment-related factors. These findings provide preliminary evidence that polymorphisms in IL1B may serve as a potential risk factor for persistent fatigue in the aftermath of cancer.

PMID:
18617366
[PubMed - indexed for MEDLINE]
PMCID:
PMC2783767
Free PMC Article

Images from this publication.See all images (1)Free text

Fig. 1
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Write to the Help Desk